- kalina
- 06 Sep, 2002
- New York City
Low valuations of industry top dogs and demographic changes in U.S. society offer good opportunities to investors seeking long-term gains. Find out which companies have real value.
- vanya
- 04 Sep, 2002
- New York City
A shaky market scenario has forced investors to diversify their portfolios and seek refuge in real estate, particularly REITs, - due to their relative stability and high yields.
- iliana
- 30 Aug, 2002
- New York City
For 16 straight years Harley-Davidson has given both investors and customers the same service - a smooth ride. But with stiff competition and aging riders the ride may turn bumpy.
- kalina
- 22 Aug, 2002
- New York City
NPS Pharmaceuticals has been showing strength amidst the market uncertainty and is likely to perform even better as long as investor sentiment remains positive.
- vanya
- 21 Aug, 2002
- New York City
Sometimes, something small draws big bets. MEMS is one such example - it has lured scores of VCs and players, big and small. Will the fledgling technology deliver on its promise?
- iliana
- 14 Aug, 2002
- New York City
Riding high in the robust housing market, Williams-Sonoma has consistently reported strong results. And though its price has soared, the stock is still a worthy long-term holding.
- kalina
- 13 Aug, 2002
- New York City
The increasing pressure on biotech companies to get new drugs to the market has triggered a new wave of merger and acquisition activity in the sector.
- vanya
- 09 Aug, 2002
- New York City
In contrast to the gloom surrounding public biotech players, VCs have pushed life sciences into the mainstream, pouring funds into biotech, medical devices and healthcare start-ups
- vicky
- 04 Aug, 2002
- New York City
In the case of wireless handset makers, depressed stock prices and the recent Wall Street rebound do not represent a buying opportunity - barring a couple of exceptions.
- iliana
- 01 Aug, 2002
- New York City
Though short-term sand traps lurk in the golf arena, Callaway's innovative products and cash-generating business offer good chances for investors to emerge as long-term winners
- kalina
- 01 Aug, 2002
- New York City
Despite the uncertainty over the timeline for FluMist's approval by the FDA, MedImmune may still launch the vaccine during the 2002/2003 flu season and cheer investors.
- vanya
- 29 Jul, 2002
- New York City
E-learning has not escaped unscathed from the tech downturn and still has a few lessons of its own to learn. However, long-term prospects for the industry seem quite good.
- iliana
- 19 Jul, 2002
- New York City
The expanding number of plus-size American women makes Charming Shoppers a sure-fire beneficiary of this growing segment and draws investor attention towards the company stock.
- kalina
- 18 Jul, 2002
- New York City
The 14th International AIDS Conference, that aimed at intensifying the battle against AIDS, offered information on a wide range of medical and scientific research on the problem.